George Tidmarsh and Vinay Prasad have taken leadership roles at CDER and CBER, respectively, impacting FDA's drug and ...
Morning Overview on MSN
AI is accused of aiding a murder for the first time
The idea that a chatbot could be blamed for a killing has moved from science fiction into a courtroom, where lawyers are now ...
Discovering effective drug combinations may now be easier thanks to a screening platform made public today by St. Jude ...
The FDA has qualified AI-Based Histologic Measurement of NASH, or AIM-NASH — the first AI drug development tool — to assist ...
Company forms a new subsidiary, Avalon Quantum AI, LLC, in connection with the acquisitionAcquisition expected to resolve Nasdaq minimum ...
More on AI: When it comes to folding AI tools into mammograms, AI firms believe there’s even more knowledge to be gleaned ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only identifies disease-causing genetic mutations but also predicts the type of ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only ...
Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, ...
The FDA’s implementation of AI tools marks the next step in the agency’s digital transformation efforts. Lets take a closer ...
Obsessing over model version matters less than workflow.
For those who want to see a doctor, supported by AI or not, opting for care at outpatient facilities or telehealth options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback